{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,2]],"date-time":"2026-11-02T13:19:27Z","timestamp":1793625567846,"version":"4.5.0"},"reference-count":84,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2020,1,1]],"date-time":"2020-01-01T00:00:00Z","timestamp":1577836800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,1,1]],"date-time":"2020-01-01T00:00:00Z","timestamp":1577836800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2020,1,11]],"date-time":"2020-01-11T00:00:00Z","timestamp":1578700800000},"content-version":"vor","delay-in-days":10,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001412","name":"Council of Scientific and Industrial Research, India","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001412","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["cell.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Heliyon"],"published-print":{"date-parts":[[2020,1]]},"DOI":"10.1016\/j.heliyon.2020.e03217","type":"journal-article","created":{"date-parts":[[2020,1,27]],"date-time":"2020-01-27T02:35:08Z","timestamp":1580092508000},"page":"e03217","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":276,"title":["Coumarin: An emerging antiviral agent"],"prefix":"10.1016","volume":"6","author":[{"given":"Shruti","family":"Mishra","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Achyut","family":"Pandey","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Siddharth","family":"Manvati","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.heliyon.2020.e03217_bib1","doi-asserted-by":"crossref","first-page":"2619","DOI":"10.3390\/md8102619","article-title":"Antiviral lead compounds from marine sponges","author":"Sagar","year":"2010","journal-title":"Mar. Drugs"},{"key":"10.1016\/j.heliyon.2020.e03217_bib2","doi-asserted-by":"crossref","DOI":"10.1021\/acsinfecdis.6b00041","article-title":"Therapeutic potential of spirooxindoles as antiviral agents","author":"Ye","year":"2016","journal-title":"ACS Infect. Dis."},{"key":"10.1016\/j.heliyon.2020.e03217_bib3","first-page":"1","article-title":"Benzouracil \u2013 coumarin \u2013 arene conjugates as inhibiting agents for chikungunya virus","author":"Ru","year":"2015","journal-title":"Antivir. Res."},{"issue":"2","key":"10.1016\/j.heliyon.2020.e03217_bib4","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1021\/acsmedchemlett.6b00487","article-title":"Novel 2-substituted 7-azaindole and 7-azaindazole analogues as potential anti-viral agents for the treatment of influenza","volume":"8","author":"Bandarage","year":"2017","journal-title":"ACS Med. Chem. Lett."},{"key":"10.1016\/j.heliyon.2020.e03217_bib5","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1016\/j.jep.2015.03.019","article-title":"In vitro evaluation of the antiviral properties of Shilajit and investigation of its mechanisms of action","volume":"166","author":"Cagno","year":"2015","journal-title":"J.\u00a0Ethnopharmacol."},{"key":"10.1016\/j.heliyon.2020.e03217_bib6","article-title":"Double-winged 3 - hydroxypyrimidine-2,4-diones: potent and selective inhibition against HIV - 1 RNase H with signi fi cant antiviral activity","author":"V Vernekar","year":"2017","journal-title":"J.\u00a0Med. Chem."},{"key":"10.1016\/j.heliyon.2020.e03217_bib7","doi-asserted-by":"crossref","first-page":"20162562","DOI":"10.1098\/rspb.2016.2562","article-title":"Why does drug resistance readily evolve but vaccine resistance does not?","volume":"284","author":"Kennedy","year":"2017","journal-title":"Proc. R. Soc. B: Biol. Sci."},{"issue":"5","key":"10.1016\/j.heliyon.2020.e03217_bib8","doi-asserted-by":"crossref","first-page":"545","DOI":"10.2217\/fvl.11.36","article-title":"Antiviral drug development","volume":"6","author":"Field","year":"2011","journal-title":"Future Virol."},{"key":"10.1016\/j.heliyon.2020.e03217_bib9","doi-asserted-by":"crossref","first-page":"695","DOI":"10.1128\/CMR.00102-15","article-title":"Approved antiviral drugs over the past 50 years","volume":"29","author":"De Clercq","year":"2016","journal-title":"Clin. Microbiol. Rev."},{"key":"10.1016\/j.heliyon.2020.e03217_bib10","first-page":"1","article-title":"The signaling pathways, and therapeutic targets of antiviral agents: focusing on the antiviral approaches and clinical perspectives of anthocyanins in the management of viral diseases","volume":"10","author":"Pour","year":"2019","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.heliyon.2020.e03217_bib11","first-page":"3","article-title":"Natural Antivirals against Human Viruses Bitter melon","volume":"3","author":"Mycol","year":"2014","journal-title":"Virol. Mycol."},{"key":"10.1016\/j.heliyon.2020.e03217_bib12","doi-asserted-by":"crossref","first-page":"24","DOI":"10.4103\/2225-4110.124335","article-title":"Antiviral natural products and herbal medicines","volume":"4","author":"Lin","year":"2014","journal-title":"J.\u00a0Tradit. Complement. Med."},{"key":"10.1016\/j.heliyon.2020.e03217_bib13","doi-asserted-by":"crossref","first-page":"692","DOI":"10.1016\/j.jff.2017.12.017","article-title":"Antiviral potential of curcumin","volume":"40","author":"Mathew","year":"2018","journal-title":"J.\u00a0Funct. Foods."},{"key":"10.1016\/j.heliyon.2020.e03217_bib14","doi-asserted-by":"crossref","DOI":"10.1016\/j.compbiolchem.2017.11.001","article-title":"Antiviral potential of natural compounds against influenza virus hemagglutinin","author":"Kannan","year":"2017","journal-title":"Comput. Biol. Chem."},{"key":"10.1016\/j.heliyon.2020.e03217_bib15","article-title":"Antiviral ability of Kalanchoe gracilis leaf extract against Enterovirus 71 and coxsackievirus A16, Evidence-Based Complement","volume":"2012","author":"Wang","year":"2012","journal-title":"Altern. Med."},{"key":"10.1016\/j.heliyon.2020.e03217_bib16","doi-asserted-by":"crossref","first-page":"1325","DOI":"10.2174\/092986710790936284","article-title":"Coumarins: old compounds with novel promising therapeutic perspectives","author":"Riveiro","year":"2010","journal-title":"Curr. Med. Chem."},{"key":"10.1016\/j.heliyon.2020.e03217_bib17","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1016\/j.antiviral.2017.04.006","article-title":"Characterization of three small molecule inhibitors of enterovirus 71 identified from screening of a library of natural products","volume":"143","author":"Li","year":"2017","journal-title":"Antivir. Res."},{"key":"10.1016\/j.heliyon.2020.e03217_bib18","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2016.07.056","article-title":"Therapeutic potential of coumarins as antiviral agents","author":"Hassan","year":"2016","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.heliyon.2020.e03217_bib19","doi-asserted-by":"crossref","DOI":"10.1155\/2013\/963248","article-title":"Review on natural coumarin lead compounds for their pharmacological activity","author":"Venugopala","year":"2013","journal-title":"BioMed Res. Int."},{"key":"10.1016\/j.heliyon.2020.e03217_bib20","doi-asserted-by":"crossref","DOI":"10.3390\/molecules23020250","article-title":"Coumarin: a natural, privileged and versatile scaffold for bioactive compounds","author":"Stefanachi","year":"2018","journal-title":"Molecules"},{"key":"10.1016\/j.heliyon.2020.e03217_bib21","article-title":"Progress in the chemistry of naturally occurring coumarins","author":"Sarker","year":"2017","journal-title":"Prog. Chem. Org. Nat. Prod."},{"key":"10.1016\/j.heliyon.2020.e03217_bib22","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1039\/JS8682100053","article-title":"On the artificial production of coumarin and formation of its homologues","author":"PERKIN","year":"1868","journal-title":"J.\u00a0Chem. Soc."},{"key":"10.1016\/j.heliyon.2020.e03217_bib23","doi-asserted-by":"crossref","first-page":"8522","DOI":"10.1021\/acsomega.9b00257","article-title":"Heterogeneously catalyzed Pechmann condensation employing the tailored Zn0. 925Ti0. 075O NPs: synthesis of coumarin","volume":"4","author":"Jadhav","year":"2019","journal-title":"ACS Omega"},{"key":"10.1016\/j.heliyon.2020.e03217_bib24","doi-asserted-by":"crossref","first-page":"473","DOI":"10.2174\/1386207043328544","article-title":"Privileged Structures\u00a0;: applications in drug discovery","author":"Desimone","year":"2004","journal-title":"Comb. Chem. High Throughput Screen."},{"key":"10.1016\/j.heliyon.2020.e03217_bib25","first-page":"1","article-title":"Pharmacological and nutritional effects of natural coumarins and their structure-activity relationships","author":"Zhu","year":"2018","journal-title":"Mol. Nutr. Food Res."},{"key":"10.1016\/j.heliyon.2020.e03217_bib26","first-page":"1","article-title":"Role of medicinal plants in HIV\/AIDS therapy","author":"Laila","year":"2019","journal-title":"Clin. Exp. Pharmacol. Physiol."},{"key":"10.1016\/j.heliyon.2020.e03217_bib27","article-title":"A\u00a0review on pharmacological properties of coumarins","author":"Srikrishna","year":"2017","journal-title":"Mini Rev. Med. Chem."},{"key":"10.1016\/j.heliyon.2020.e03217_bib28","doi-asserted-by":"crossref","first-page":"606","DOI":"10.1016\/j.bmcl.2012.12.034","article-title":"Inhibition of HIV-1 replication by a tricyclic coumarin GUT-70 in acutely and chronically infected cells","volume":"23","author":"Kudo","year":"2013","journal-title":"Bioorg. Med. Chem. Lett"},{"key":"10.1016\/j.heliyon.2020.e03217_bib29","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1159\/000500963","article-title":"Treatment of chronic hepatitis C: efficacy, side effects and complications","volume":"35","author":"Sandmann","year":"2019","journal-title":"Vis. Med."},{"key":"10.1016\/j.heliyon.2020.e03217_bib30","doi-asserted-by":"crossref","first-page":"1350","DOI":"10.1136\/gut.2005.076646","article-title":"Treating viral hepatitis C: efficacy, side effects, and complications","volume":"55","author":"Manns","year":"2006","journal-title":"Gut"},{"key":"10.1016\/j.heliyon.2020.e03217_bib31","first-page":"2014","article-title":"Cutaneous side-effects of antihepatitis C treatment;: the U. K. experience","author":"Ly","year":"2014","journal-title":"Br. J. Dermatol."},{"key":"10.1016\/j.heliyon.2020.e03217_bib32","first-page":"265","article-title":"Drug pricing & challenges to hepatitis C treatment access","volume":"14","author":"Henry","year":"2018","journal-title":"J.\u00a0Heal. Biomed. Law."},{"key":"10.1016\/j.heliyon.2020.e03217_bib33","doi-asserted-by":"crossref","DOI":"10.3390\/molecules21020228","article-title":"Synthesis and Structure-activity relationships of imidazole-coumarin conjugates against hepatitis C virus","author":"Tsay","year":"2016","journal-title":"Molecules"},{"key":"10.1016\/j.heliyon.2020.e03217_bib34","first-page":"589","article-title":"Association between high serum alanine aminotransferase levels and more rapid development and higher rate of incidence of hepatocellular carcinoma in patients with hepatitis C virus-associated cirrhosis","author":"Rino","year":"1999","journal-title":"Cancer"},{"key":"10.1016\/j.heliyon.2020.e03217_bib35","first-page":"20","article-title":"Close association between high serum ALT and more rapid recurrence of hepatocellular carcinoma in hepatectomized patients with HCV-associated liver cirrhosis and hepatocellular carcinoma","year":"2000","journal-title":"Intervirology"},{"key":"10.1016\/j.heliyon.2020.e03217_bib36","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1254\/jjp.87.177","article-title":"Hepatoprotective drugs for the treatment of virus-induced chronic hepatitis;: from hypercarcinogenic state to hypocarcinogenic state","volume":"180","author":"Okamoto","year":"2001","journal-title":"Jpn. J. Pharmacol."},{"key":"10.1016\/j.heliyon.2020.e03217_bib37","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/j.antiviral.2007.09.003","article-title":"Synthesis of new benzimidazole \u2013 coumarin conjugates as anti-hepatitis C virus agents","volume":"77","author":"Ru","year":"2008","journal-title":"Antivir. Res."},{"key":"10.1016\/j.heliyon.2020.e03217_bib38","article-title":"Coumarins hinged directly on benzimidazoles and their ribofuranosides to inhibit hepatitis C virus","author":"Hsu","year":"2013","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.heliyon.2020.e03217_bib39","doi-asserted-by":"crossref","first-page":"1486","DOI":"10.1021\/jm801240d","article-title":"Structure - activity relationship of new anti-hepatitis C virus agents: heterobicycle - coumarin conjugates","author":"Neyts","year":"2009","journal-title":"J.\u00a0Med. Chem."},{"key":"10.1016\/j.heliyon.2020.e03217_bib40","doi-asserted-by":"crossref","first-page":"2114","DOI":"10.1021\/jm101337v","article-title":"Coumarin - purine ribofuranoside conjugates as new agents against hepatitis C virus","author":"Hwu","year":"2011","journal-title":"J.\u00a0Med. Chem."},{"issue":"5","key":"10.1016\/j.heliyon.2020.e03217_bib41","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1111\/cbdd.12105","article-title":"Evaluation of coumarin and neoflavone derivatives as HCV NS 5 B polymerase inhibitors","volume":"81","author":"Nichols","year":"2013","journal-title":"Chem. Biol. Drug Des."},{"key":"10.1016\/j.heliyon.2020.e03217_bib42","doi-asserted-by":"crossref","first-page":"1858","DOI":"10.1039\/c2ob26860d","article-title":"Novel anilinocoumarin derivatives as agents against hepatitis C virus by the induction of IFN-mediated antiviral responses","author":"Peng","year":"2013","journal-title":"Org. Biomol. Chem."},{"issue":"1","key":"10.1016\/j.heliyon.2020.e03217_bib43","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1016\/S0031-9422(96)00532-8","article-title":"Two coumarins from the root bark of Clausena excavata","volume":"44","author":"Huang","year":"1997","journal-title":"Phytochemistry"},{"key":"10.1016\/j.heliyon.2020.e03217_bib44","doi-asserted-by":"crossref","first-page":"6137","DOI":"10.1016\/j.bmc.2008.12.007","article-title":"Bioorganic & Medicinal Chemistry Anti-HBV and cytotoxic activities of pyranocoumarin derivatives","volume":"17","author":"Su","year":"2009","journal-title":"Bioorg. Med. Chem."},{"key":"10.1016\/j.heliyon.2020.e03217_bib45","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1038\/35036060","article-title":"New targets for inhibitors of HIV-1 replication","volume":"1","author":"Moore","year":"2000","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"10.1016\/j.heliyon.2020.e03217_bib46","doi-asserted-by":"crossref","first-page":"108","DOI":"10.4172\/pharmaceutical-sciences.1000335","article-title":"Synthesis and antiretroviral activity of 6-Acetyl-coumarin derivatives against HIV-1 infection","volume":"80","author":"Srivastav","year":"2018","journal-title":"Indian J. Pharm. Sci."},{"key":"10.1016\/j.heliyon.2020.e03217_bib47","doi-asserted-by":"crossref","first-page":"S1081","DOI":"10.1016\/j.arabjc.2013.01.015","article-title":"QSAR and docking studies of coumarin derivatives as potent HIV-1 integrase inhibitors","volume":"10","author":"Srivastav","year":"2017","journal-title":"Arab. J. Chem."},{"key":"10.1016\/j.heliyon.2020.e03217_bib48","article-title":"Evaluation of novel N\u2032-(3-hydroxybenzoyl)-2-oxo-2H-chromene-3-carbohydrazide derivatives as potential HIV-1 integrase inhibitors","author":"Jesumoroti","year":"2018","journal-title":"MedChemComm"},{"key":"10.1016\/j.heliyon.2020.e03217_bib49","first-page":"65","article-title":"Design, synthesis, molecular modeling, in silico ADME studies and anti- HIV-1 assay of new diazocoumarin derivatives","volume":"17","author":"Alimi","year":"2018","journal-title":"Iran. J. Pharm. Res. (IJPR):"},{"key":"10.1016\/j.heliyon.2020.e03217_bib50","doi-asserted-by":"crossref","first-page":"1740","DOI":"10.1248\/cpb.55.1740","article-title":"Synthesis and HIV-1 integrase inhibition of novel bis- or tetra-coumarin analogues","volume":"55","author":"Chiang","year":"2007","journal-title":"Chem. Pharm. Bull."},{"key":"10.1016\/j.heliyon.2020.e03217_bib51","doi-asserted-by":"crossref","first-page":"2664","DOI":"10.1021\/jm00043a006","article-title":"A\u00a0novel nonpeptide HIV-1 protease inhibitor: elucidation of the binding mode and its application in the design of related analogs","author":"Lunney","year":"1994","journal-title":"J.\u00a0Med. Chem."},{"key":"10.1016\/j.heliyon.2020.e03217_bib52","first-page":"1","article-title":"Bioorganic & Medicinal Chemistry Synthesis and evaluation of coumarin derivatives as potential dual-action HIV-1 protease and reverse transcriptase inhibitors","author":"Olomola","year":"2013","journal-title":"Bioorg. Med. Chem."},{"key":"10.1016\/j.heliyon.2020.e03217_bib53","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1016\/j.bbrc.2014.12.102","article-title":"Inhibition of HIV-1 entry by the tricyclic coumarin GUT-70 through the modification of membrane fluidity","volume":"457","author":"Matsuda","year":"2015","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.heliyon.2020.e03217_bib55","doi-asserted-by":"crossref","first-page":"480","DOI":"10.1016\/j.bbrc.2005.02.007","article-title":"Influence of membrane fluidity on human immunodeficiency virus type 1 entry","volume":"329","author":"Harada","year":"2005","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.heliyon.2020.e03217_bib56","first-page":"2","article-title":"Neoflavonoids as inhibitors of HIV-1 replication by targeting the Tat and NF- \u03ba B pathways","author":"Olmedo","year":"2017","journal-title":"Molecules"},{"key":"10.1016\/j.heliyon.2020.e03217_bib57","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1016\/j.antiviral.2005.02.006","article-title":"Mesuol, a natural occurring 4-phenylcoumarin, inhibits HIV-1 replication by targeting the NF-\u03baB pathway","volume":"66","author":"M\u00e1rquez","year":"2005","journal-title":"Antivir. Res."},{"key":"10.1016\/j.heliyon.2020.e03217_bib58","doi-asserted-by":"crossref","first-page":"484","DOI":"10.2174\/1570162X14666161003152458","article-title":"Reactivation of latent HIV-1 in latently infected cells by coumarin compounds: hymecromone and scoparone","author":"Li","year":"2016","journal-title":"Curr. HIV Res."},{"key":"10.1016\/j.heliyon.2020.e03217_bib59","doi-asserted-by":"crossref","first-page":"1325","DOI":"10.1586\/14787210.2014.966083","article-title":"A\u00a0review of neuraminidase inhibitor susceptibility in influenza strains","author":"Spanakis","year":"2014","journal-title":"Expert Rev. Anti-infect. Ther."},{"key":"10.1016\/j.heliyon.2020.e03217_bib60","doi-asserted-by":"crossref","first-page":"2920","DOI":"10.1016\/j.bmcl.2017.04.091","article-title":"Bioorganic & medicinal chemistry letters anti-influenza activity of monoterpene-containing substituted coumarins","volume":"27","author":"Khomenko","year":"2017","journal-title":"Bioorg. Med. Chem. Lett"},{"key":"10.1016\/j.heliyon.2020.e03217_bib61","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1016\/j.biopha.2016.12.117","article-title":"Inhibition viral RNP and anti-in fl ammatory activity of coumarins against in fl uenza virus","volume":"87","author":"Wang","year":"2017","journal-title":"Biomed. Pharmacother."},{"key":"10.1016\/j.heliyon.2020.e03217_bib62","first-page":"2776","article-title":"Eleutheroside B1 mediates its anti-influenza activity through POLR2A and N-glycosylation","author":"Yan","year":"2018","journal-title":"Int. J. Mol. Med."},{"key":"10.1016\/j.heliyon.2020.e03217_bib63","doi-asserted-by":"crossref","DOI":"10.1016\/j.molstruc.2018.04.031","article-title":"New thiazolyl-coumarin hybrids: design, synthesis, characterization, X-ray crystal structure, antibacterial and antiviral evaluation","author":"Osman","year":"2018","journal-title":"J.\u00a0Mol. Struct."},{"key":"10.1016\/j.heliyon.2020.e03217_bib64","doi-asserted-by":"crossref","first-page":"1494","DOI":"10.1080\/00397911.2018.1455871","article-title":"Bis coumarinyl bis triazolothiadiazinyl ethane derivatives: synthesis, antiviral activity evaluation, and molecular docking studies ARTICLE HISTORY","volume":"48","author":"Pavurala","year":"2018","journal-title":"Synth. Commun."},{"key":"10.1016\/j.heliyon.2020.e03217_bib65","doi-asserted-by":"crossref","first-page":"971","DOI":"10.1016\/j.bmcl.2009.12.106","article-title":"Bioorganic & Medicinal Chemistry Letters Inhibition of neuraminidase activity by polyphenol compounds isolated from the roots of Glycyrrhiza uralensis","volume":"20","author":"Bae","year":"2010","journal-title":"Bioorg. Med. Chem. Lett"},{"key":"10.1016\/j.heliyon.2020.e03217_bib66","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/j.jcv.2007.10.019","article-title":"Detection of human influenza A ( H1N1 ) and B strains with reduced sensitivity to neuraminidase inhibitors","volume":"41","author":"Escuret","year":"2008","journal-title":"J.\u00a0Clin. Virol."},{"key":"10.1016\/j.heliyon.2020.e03217_bib67","doi-asserted-by":"crossref","DOI":"10.1021\/acs.jnatprod.7b00665","article-title":"Regioselective IBX-mediated synthesis of coumarin derivatives with antioxidant and anti-in fl uenza activities","author":"Bizzarri","year":"2017","journal-title":"J.\u00a0Nat. Prod."},{"key":"10.1016\/j.heliyon.2020.e03217_bib68","first-page":"1","article-title":"Antiviral effect of compounds derived from the seeds of Mammea americana and Tabernaemontana cymosa on Dengue and Chikungunya virus infections","author":"G\u00f3mez-calder\u00f3n","year":"2017","journal-title":"BMC Complement Altern. Med."},{"key":"10.1016\/j.heliyon.2020.e03217_bib69","doi-asserted-by":"crossref","first-page":"2005","DOI":"10.1038\/nsmb1073","article-title":"Structural basis for the activation of flaviviral NS3 proteases from dengue and West Nile virus","volume":"13","author":"Erbel","year":"2006","journal-title":"Nat. Struct. Mol. Biol."},{"key":"10.1016\/j.heliyon.2020.e03217_bib70","first-page":"1","article-title":"4 - thiazolidinone coumarin derivatives as two - component NS2B\/NS3 DENV flavivirus serine protease inhibitors: synthesis, molecular docking, biological evaluation and structure \u2013 activity relationship studies","author":"Yusufzai","year":"2018","journal-title":"Chem. Cent. J."},{"key":"10.1016\/j.heliyon.2020.e03217_bib71","first-page":"250","article-title":"Phytochemical study of Myrtopsis corymbosa, perspectives for Anti-dengue natural compound research","volume":"3","author":"Coulerie","year":"2013","journal-title":"Rec. Nat. Prod."},{"key":"10.1016\/j.heliyon.2020.e03217_bib72","first-page":"1","article-title":"Resveratrol treatment reveals a novel role for HMGB1 in regulation of the type 1 interferon response in dengue virus infection","author":"Zainal","year":"2017","journal-title":"Nat. Publ. Gr."},{"key":"10.1016\/j.heliyon.2020.e03217_bib73","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1016\/j.ejmech.2019.01.037","article-title":"European Journal of Medicinal Chemistry Chikungunya virus inhibition by synthetic coumarin e guanosine conjugates","volume":"166","author":"Ru","year":"2019","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.heliyon.2020.e03217_bib74","doi-asserted-by":"crossref","DOI":"10.1016\/j.antiviral.2017.06.015","article-title":"Identification of a coumarin-based antihistamine as an anti-filoviral entry inhibitor","author":"Cheng","year":"2017","journal-title":"Antivir. Res."},{"key":"10.1016\/j.heliyon.2020.e03217_bib75","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/j.fsi.2018.07.005","article-title":"Fish and Shell fi sh Immunology Synthesis and antiviral activity of a new coumarin derivative against spring viraemia of carp virus","volume":"81","author":"Shen","year":"2018","journal-title":"Fish Shellfish Immunol."},{"key":"10.1016\/j.heliyon.2020.e03217_bib76","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/j.virusres.2019.05.007","article-title":"Antiviral e ffi ciency of a coumarin derivative on spring viremia of carp virus in vivo","volume":"268","author":"Liu","year":"2019","journal-title":"Virus Res."},{"key":"10.1016\/j.heliyon.2020.e03217_bib77","article-title":"PT key laboratory of applied marine biotechnology of ministry of education, ningbo","author":"Chen","year":"2018","journal-title":"Cell. Signal."},{"key":"10.1016\/j.heliyon.2020.e03217_bib78","article-title":"An imidazole coumarin derivative enhances the antiviral response to spring viremia of carp virus infection in zebrafish Authors: SC","author":"Liu","year":"2019","journal-title":"Virus Res."},{"key":"10.1016\/j.heliyon.2020.e03217_bib79","doi-asserted-by":"crossref","first-page":"e10","DOI":"10.1097\/CCM.0b013e3181ceb25b","article-title":"The 1918 influenza pandemic: lessons for 2009 and the future","volume":"38","author":"Morens","year":"2010","journal-title":"Crit. Care Med."},{"issue":"9","key":"10.1016\/j.heliyon.2020.e03217_bib80","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1016\/S1473-3099(12)70121-4","article-title":"Estimated global mortality associated with the first 12 months of 2009 pandemic influenza A H1N1 virus circulation: a modelling study","volume":"12","author":"Dawood","year":"2012","journal-title":"Lancet Infect. Dis."},{"key":"10.1016\/j.heliyon.2020.e03217_bib81","series-title":"Cumulative Number of Confirmed Human Cases for Avian Influenza A (H5N1) Reported to WHO, 2003-2019","author":"World Health Organization","year":"2019"},{"key":"10.1016\/j.heliyon.2020.e03217_bib82","series-title":"Up to 650 000 people die of respiratory diseases linked to seasonal flu each year","author":"World Health Organization","year":"2017"},{"key":"10.1016\/j.heliyon.2020.e03217_bib83","series-title":"Global Hepatitis Report 2017","year":"2017"},{"key":"10.1016\/j.heliyon.2020.e03217_bib84","series-title":"Global, H. I. V. AIDS Statistics\u20132018 Fact Sheet","year":"2019"},{"key":"10.1016\/j.heliyon.2020.e03217_bib85","series-title":"Global Strategy for Dengue Prevention and Control: 2012\u20132020","author":"World Health Organization","year":"2018"}],"container-title":["Heliyon"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2405844020300621?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2405844020300621?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,12,30]],"date-time":"2025-12-30T09:24:53Z","timestamp":1767086693000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2405844020300621"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,1]]},"references-count":84,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2020,1]]}},"alternative-id":["S2405844020300621"],"URL":"https:\/\/doi.org\/10.1016\/j.heliyon.2020.e03217","relation":{},"ISSN":["2405-8440"],"issn-type":[{"value":"2405-8440","type":"print"}],"subject":[],"published":{"date-parts":[[2020,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Coumarin: An emerging antiviral agent","name":"articletitle","label":"Article Title"},{"value":"Heliyon","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.heliyon.2020.e03217","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"e03217"}}